Company or ticker...

Denali Therapeutics

Denali develops medicines for neurodegenerative and lysosomal storage diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

DNLI

3.2B

1,004.1

n/a

21.25%

Key Facts

M. Cap

PS

PE

YTD

3.2B

1,004.1

n/a

21.25%

10MA

20MA

50MA

200MA

$DNLI